| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 03/05/2008 | CN101137660A Benzothiazole, thiazolopyridine, benzooxazole and oxazolopyridine derivatives as antidiabetic compounds |
| 03/05/2008 | CN101137631A Heteroaromatic glucokinase activators |
| 03/05/2008 | CN101137630A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137629A Non-anilinic derivatives of isothiazol-3(2h)-thione 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137628A Non-anilinic derivatives of isothiazol-3(2h)-one 1,1-dioxides as liver x receptor modulators |
| 03/05/2008 | CN101137397A Amyloid imaging as a surrogate marker for efficacy of anti-amyloid therapies |
| 03/05/2008 | CN101137390A Novel angiogensis inhibitor |
| 03/05/2008 | CN101137373A Pharmaceutical compositions containing a combination of a cannabinoid receptor antagonist compound and an antipsychotic agent |
| 03/05/2008 | CN101137368A Roflumilast for the treatment of diabetes mellitus |
| 03/05/2008 | CN101137366A Compounds for treating autoimmune and demyelinating diseases |
| 03/05/2008 | CN101134935A Rejuvenation liquor |
| 03/05/2008 | CN101134757A 稠合杂环化合物 Fused heterocyclic compounds |
| 03/05/2008 | CN101134756A Novel pharmaceutical |
| 03/05/2008 | CN101134745A Nitric oxide donator type telmisartan derivant, preparation method and medical uses thereof |
| 03/05/2008 | CN101134739A Novel beta-lactam compound and preparation method and chemical uses thereof |
| 03/05/2008 | CN101134723A Gallic acid and divalent metal ionic compound and preparation method and application thereof |
| 03/05/2008 | CN101134083A Chinese medicinal herb capsule for treating diabetes and its complication and method for preparing the same |
| 03/05/2008 | CN101134079A Slimming agent made by garlic |
| 03/05/2008 | CN101134058A Health products having blood fat and blood pressure reducing functions and manufacturing method thereof |
| 03/05/2008 | CN101134050A Pharmaceutical composition for reinforcing organism immunity and technique of preparing the same |
| 03/05/2008 | CN101134045A Diabetes treating medicine |
| 03/05/2008 | CN101134043A Galenical for regulating and controlling blood sugar in physics method |
| 03/05/2008 | CN101134021A Glipizide oral cavity disintegrating lyophilized tablets and method for preparing the same |
| 03/05/2008 | CN101133788A Wilding mineral composition synthesized five-corn three-ginseng double-blossom compressed granules beverage and method of processing the same |
| 03/05/2008 | CN101133787A Wilding synthesized black rice black soya bean compressed food granules beverage and method of processing the same |
| 03/05/2008 | CN100372848C Spiroazacyclic compounds as monoamine receptor modulators |
| 03/05/2008 | CN100372845C Polycyclic compounds as potent alpha2-adrenoceptor antagonists |
| 03/05/2008 | CN100372548C Compound capsule with omega-3 fatty acid as main component and its preparing process |
| 03/05/2008 | CN100372544C Silkworm sand total alkaloid and preparation thereof |
| 03/05/2008 | CN100372529C Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 03/05/2008 | CN100372482C Production method of peanut stem extract for regulating blood sugar |
| 03/04/2008 | US7339047 Comprises nucleotide sequences coding interleukin-1b converting enzyme ligand for use in diagnosis, prevention and treatment of autoimmune, connective tissue and crohn's diseases |
| 03/04/2008 | US7339023 Angiogenesis inhibitors, antitumor agents |
| 03/04/2008 | US7338960 {[2-Methyl-4-({[4'-(trifluoromethyl)-3-biphenylyl]methyl}thio)phenyl]oxy}acetic acid; adipogenic signalling cascade and lipid homeostasis; increase High Density Lipoproteins; hypotensive agent; Syndrome X, obesity, insulin resistance, cardiovascular disorder |
| 03/04/2008 | US7338953 Administering racemic reboxetine or a salt thereof for inhibition of norepinephrine reuptake |
| 03/04/2008 | US7338941 Identifying a mammal; administering isovitexin or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof |
| 03/04/2008 | US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate |
| 03/04/2008 | US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis |
| 03/01/2008 | CA2558465A1 Fat metabolism improving agent |
| 02/28/2008 | WO2008024390A2 2- (pyrazin-2-yl) -thiazole and 2- (1h-pyraz0l-3-yl) -thiazole derivatives as well as related compounds as stearoyl-coa desaturase (scd) inhibitors for the treatment of metabolic, cardiovascular and other disorders |
| 02/28/2008 | WO2008024374A2 Inhibitors of pancreatic phospholipase a2 for altering cholesterol and fat uptake |
| 02/28/2008 | WO2008024298A1 Bis(thiohydrazide amides) for inhibiting angiogenesis |
| 02/28/2008 | WO2008024029A1 Substituted azepino[4,3-b]indoles, pharmacological composition and a method for the production and use thereof |
| 02/28/2008 | WO2008023608A1 Lipid-metabolism-ameliorating agent |
| 02/28/2008 | WO2008023050A1 Acylated exendin-4 compounds |
| 02/28/2008 | WO2008022974A2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 02/28/2008 | WO2008009335A3 Aminoindazole urea derivatives |
| 02/28/2008 | WO2008000692A3 Pyrimidine and quinazoline derivatives as modulators of somatostatine receptor activity |
| 02/28/2008 | WO2007145539A3 Crystal structure of a substrate complex of miox |
| 02/28/2008 | WO2007120270A3 Glucagon receptor antagonists, preparation and therapeutic uses |
| 02/28/2008 | WO2007104034A3 Glucokinase activators |
| 02/28/2008 | US20080051452 Hexanoic acid derivatives as dipeptidyl peptidase inhibitors |
| 02/28/2008 | US20080051447 Treatment Of Hypercholesterolemia, Hypertriglyceridemia And Cardiovascular-Related Conditions Using Phospholipase-A2 Inhibitors |
| 02/28/2008 | US20080051444 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051443 Compounds for the reduction of excessive food intake |
| 02/28/2008 | US20080051440 Compositions for weight management |
| 02/28/2008 | US20080051439 Methods of food intake management |
| 02/28/2008 | US20080051433 Pyrrole-3-Carboxamide Derivatives for the Treatment of Obesity |
| 02/28/2008 | US20080051430 Dietetics; antidiabetic agents; sexual disorders |
| 02/28/2008 | US20080051427 Pharmaceutical Compositions and Methods of Using Same |
| 02/28/2008 | US20080051423 Nitrogen heterocycle biaryls for osteoporosis and other diseases |
| 02/28/2008 | US20080051418 Arylalkanoic Acid Derivative |
| 02/28/2008 | US20080051411 choline fenofibrate, or fenofibric acid salts of ethanolamine, diethanolamine, piperazine, calcium or tromethamine; salts have improved photostability; hyperlipidemia or coronary heart diseases |
| 02/28/2008 | US20080051405 Therapeutic Agents |
| 02/28/2008 | US20080051397 with polyglycolized glyceride (macrogol glyceride); Gelucires"; multiple sclerosis, asthma, scleroderma, endometriosis; 1,3-benzothiazol-2(3H)-ylidene{2-[(1,4-dimethylpiperazin-2-yl)methoxy]pyrimidin-4-yl}acetonitrile; adding to melt as powder under stirring resulting in homogeneous molten dispersion |
| 02/28/2008 | US20080051394 6H-Oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands |
| 02/28/2008 | US20080051387 Tetrahydropyrido[3,4-d]pyrimidines and related analogues |
| 02/28/2008 | US20080051371 Membrane permeable; ischemia, heart failure, and neurodegenerative disorders |
| 02/28/2008 | US20080051341 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome |
| 02/28/2008 | US20080051339 Modulators of pharmacological agents |
| 02/28/2008 | US20080051321 Substituted arylalcanoic acid derivatives as ppar pan agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 02/28/2008 | US20080050499 Process for preparing a composition comprising steroidal glycosides |
| 02/28/2008 | US20080050454 Mixture of vitamins, minerals; for physiologically stressful states as pregnancy, lactation, nutritional deficiencies; nutraceuticals |
| 02/28/2008 | US20080050451 Methods for assessing dehydration and shock, assays and kits for the methods |
| 02/28/2008 | US20080050450 Active Agent Formulations, Methods of Making, and Methods of Use |
| 02/28/2008 | US20080050372 Inhibition of alpha-2 hs glycoprotein (ahsg/fetuin) in obesity and insulin control of glucose homeostasis |
| 02/28/2008 | US20080050368 Humanized immunoglobulin reactive with B7 molecules and methods of treatment therewith |
| 02/28/2008 | US20080050351 Gene Therapy Approaches to Supply Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorder |
| 02/28/2008 | US20080050315 Diagnostics and Therapeutics for Diseases Associated with Protein Kinase, Cgmp-Dependent, Type I (Prkg1) |
| 02/28/2008 | US20080050314 Diagnostics and Therapeutics for Diseases Associated With Glycogen Synthase Kinase 3 Beta (Gsk3b) |
| 02/28/2008 | DE602004007105T2 Zusammensetzung zur behandlung von gastrointestinalen störungen Composition for the treatment of gastrointestinal disorders |
| 02/28/2008 | CA2661503A1 Inhibitors of 11.beta. -hydroxysteroid dehydrogenase type 1 |
| 02/28/2008 | CA2661373A1 Lipid-metabolism-ameliorating agent |
| 02/28/2008 | CA2661329A1 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 02/28/2008 | CA2661017A1 Organic compounds |
| 02/28/2008 | CA2660957A1 2-phenoxy pyrimidinone analogues |
| 02/28/2008 | CA2648521A1 1.alpha.-hydroxy-2-(3'-hydroxypropylidene)-19-n0r-vitamin d compounds with a 1,1-dimethylpropyl side chain |
| 02/27/2008 | EP1892299A2 Sense mRNA therapy |
| 02/27/2008 | EP1892251A2 B7-related nucleic acids and polypeptides and their uses for immunomodulation |
| 02/27/2008 | EP1892241A1 Novel piperidine derivative |
| 02/27/2008 | EP1891972A1 Agent for promoting hepatic cell replication and agent for improving insulin resistance |
| 02/27/2008 | EP1891971A1 Medicinal composition for ameliorating or treating glucose intolerance, borderline diabetes, insulin resistance and hyperinsulinemia containing hypoglycemic agent |
| 02/27/2008 | EP1891114A2 Anti-trkb monoclonal antibodies and uses thereof |
| 02/27/2008 | EP1891105A2 Oxyntomodulin analogues and their effects on feeding behaviour |
| 02/27/2008 | EP1891074A1 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 02/27/2008 | EP1891069A1 2-phenyl substituted imidazol [4,5b]pyridine/ pyrazine and purine derivatives as glucokinase modulators |
| 02/27/2008 | EP1891065A1 Novel mchr1 antagonists and their use for the treatment of mchr1 mediated conditions and disorders |
| 02/27/2008 | EP1891058A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 02/27/2008 | EP1891012A2 Quinoline derivatives as nk3 anatgonists |
| 02/27/2008 | EP1891001A1 SULFONAMIDE DERIVATIVES USEFUL AS LIVER CARNITINE PALMITOYL TRANSFERASE (L-CPTl) INHIBITORS |